Galzin
Manufacturing · 11-50 Employees
View Company Info for Free
Overview
Website
www.galzin.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Galzin
Eton Pharmaceuticals, Inc. offers Galzin (zinc acetate), a medication indicated for the long-term maintenance treatment of Wilson's disease in patients who have previously undergone chelation therapy. The product is designed to provide reliable control and tolerability for individuals managing this lifelong condition. Their intended clients include healthcare professionals dealing with Wilson's disease patients and the patients themselves seeking effective management options. Eton also provides support resources through the Eton Cares Patient Support Program to help reduce costs for eligible patients.Explore more
Popular SearchesGalzinGALZIN ® Zinc Acetate CapsulesSIC Code 28,283NAICS Code 32,325Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Galzin your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Galzin is spiking on competitors!
Earning: See what the market has to say on Galzin recently announced quarterly report
Funding: Get notified immidiatlly once Galzin has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Galzin, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Galzin launches new products
Congratulate Masked Content for being promoted to Masked Content at Galzin
Click to see if Galzin had a recent Job posting/layoffs
Check if Galzin has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Galzin as Masked Content
Find more new buyers
Compare Similar Companies to Galzin
Compare insights from companies similar to Galzin, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Galzin
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Galzin is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Galzin is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Galzin.
Galzin Tech Stack
A closer look at the technologies used by Galzin
Galzin News & Media
Eton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) Capsules
– Eton expects to significantly expand patient access to this critical treatment for Wilson disease patients – – $0 co-pay for all eligible patients and best-in-class patient support services – – Now available exclusively through Optime Care –Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin®
DEER PARK, Ill., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it has acquired Galzin® (zinc acetate).
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Galzin
Sign Up For FreeTo access detailed company insights
Eton Pharmaceuticals, Inc. offers Galzin (zinc acetate), a medication indicated for the long-term maintenance treatment of Wilson's disease in patients who have previously undergone chelation therapy. The product is designed to provide reliable control and tolerability for individuals managing this lifelong condition. Their intended clients include... Read More
